Data Characteristics
Gene therapy AAV clinical trial pre-screening data comes from global clinical trial registries (e.g., ClinicalTrials.gov, EMA Clinical Trials Register), pharmaceutical company internal research reports, academic journal articles, and regulatory guidelines. Update frequencies vary. Clinical trial registration information typically updates at specific trial milestones, while research reports and papers depend on scientific output. Document structures are complex. They often include plain text descriptions, structured tables (e.g., subject inclusion/exclusion criteria, dose escalation schemes, adverse event reports), images (e.g., gene delivery vector diagrams, biomarker expression curves), and rich text formats for trial protocols and investigator brochures. Key fields include AAV serotype, gene vector design, target gene, dose units (e.g., vg/kg), administration route, subject population characteristics (e.g., age, disease state), and primary and secondary endpoint indicators with their assessment methods.
Constraints on Document Parsing and Chunking
The complex structure of AAV gene therapy clinical trial documents challenges document parsing. Plain text sections require precise identification of key entities, such as AAV serotypes and target gene names and abbreviations. Structured tables, especially inclusion/exclusion criteria and adverse event reports, contain multi-level nesting and conditional logic. Traditional text chunking methods struggle to extract their inherent relationships. Information within images, such as vector diagrams or biomarker expression trends, cannot be directly processed by text parsers. This requires additional image recognition or manual annotation. Standardized recognition of dose units vg/kg and administration routes is crucial for subsequent pre-screening matching. The irregular document update schedule requires parsing processes to support incremental updates and version management. Additionally, critical information scattered throughout long documents, such as detailed descriptions of specific safety events, requires fine-grained chunking to ensure recall accuracy.
Configuration Settings
| Configuration Item | Recommended Value | Rationale |
|---|---|---|
Chunk Length | 500–800 characters | Ensures the completeness of key information blocks and prevents individual chunks from becoming too long, leading to redundancy or loss of contextual relevance. |
Overlap Length | 100–150 characters | Guarantees semantic continuity between adjacent chunks, especially when describing complex trial protocols or subject screening criteria. |
PARSE_FILE_TIMEOUT_SECONDS | 600 seconds | Provides sufficient parsing time for large PDF documents or documents with complex tables, preventing parsing failures due to timeouts. |
UPLOAD_FILE_MAX_SIZE | 500 MB | Supports uploading clinical trial protocol PDFs that contain numerous charts, detailed appendices, or multiple revised versions. |
Chunking Strategy | By Title and Paragraph | Prioritizes chunking based on the document's logical structure, accommodating the common chapter divisions and paragraph organization in clinical trial documents. |
Enable Table Recognition | Yes | Identifies and parses structured tables within documents, extracting key information such as inclusion/exclusion criteria and adverse events. |
Common Pitfalls
- A document upload fails with the error message
Failed to parse document: ReadTimeout. This typically occurs when the uploaded trial protocol document is too large or complex, causing the parser to exceed the default processing time. - Knowledge base chunks are missing critical table information, such as an empty subject inclusion/exclusion criteria section. This happens when table recognition is not enabled or incorrectly configured, leading the parser to treat table content as plain text rather than extracting it structurally.
- Pre-screening results show numerous inconsistencies or incorrect identifications for AAV serotypes or target gene names. This is due to the presence of various abbreviations, aliases, or non-standard naming conventions in the document, and the parsing configuration does not include corresponding entity recognition or normalization rules.
How to Verify Configuration
- Upload a typical gene therapy AAV clinical trial protocol PDF and check if its parsing status shows "success."
- Randomly sample several parsed knowledge base chunks to ensure that critical fields such as AAV serotype, target gene, and dose units are correctly identified and included in the chunk content.
- For documents containing complex tables, verify that the parsed chunks completely and accurately include structured information from the tables, such as inclusion/exclusion criteria and adverse event reports.
- Run several queries targeting AAV clinical trial pre-screening. Observe the quality and relevance of the recall results, and evaluate the effectiveness of the parsed chunks by adjusting the
Similarity Threshold.
Note: The values provided are common starting points. Always measure against your own samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.